Accession Therapeutics
R&D/Manufacturing
- Membership category
- Corporate
Building 7600c, The Quorum Alec Issigonis Way, Oxford, OX4 2JZ, United Kingdom
Accession Therapeutics at a glance
Accession Therapeutics is focused on treating widespread forms of cancer. With its platform technology, Trocept, Accession Therapeutics is focused on treating some of the most intractable and widespread forms of cancer.
About Accession Therapeutics
Accession Therapeutics’ Trocept approach enables the company to design novel highly targeted treatments with the potential to eradicate all cells in a tumour, regardless of diversity.
This enormous increase in the ability to target tumours and wipe out cancer cells eliminates many of the drawbacks of current immunotherapies.
Accession Therapeutics is the first company to have engineered a viral point of entry to cancer cells while bypassing healthy cells.
